1. Home
  2. ADAP vs NISN Comparison

ADAP vs NISN Comparison

Compare ADAP & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • NISN
  • Stock Information
  • Founded
  • ADAP 2008
  • NISN 2005
  • Country
  • ADAP United Kingdom
  • NISN China
  • Employees
  • ADAP N/A
  • NISN N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • NISN Metal Fabrications
  • Sector
  • ADAP Health Care
  • NISN Industrials
  • Exchange
  • ADAP Nasdaq
  • NISN Nasdaq
  • Market Cap
  • ADAP 21.3M
  • NISN 19.4M
  • IPO Year
  • ADAP 2015
  • NISN 2016
  • Fundamental
  • Price
  • ADAP $0.06
  • NISN $3.78
  • Analyst Decision
  • ADAP Hold
  • NISN
  • Analyst Count
  • ADAP 6
  • NISN 0
  • Target Price
  • ADAP $1.02
  • NISN N/A
  • AVG Volume (30 Days)
  • ADAP 89.0M
  • NISN 26.1K
  • Earning Date
  • ADAP 08-13-2025
  • NISN 10-14-2025
  • Dividend Yield
  • ADAP N/A
  • NISN N/A
  • EPS Growth
  • ADAP N/A
  • NISN N/A
  • EPS
  • ADAP N/A
  • NISN 1.43
  • Revenue
  • ADAP $65,084,999.00
  • NISN $340,219,546.00
  • Revenue This Year
  • ADAP N/A
  • NISN N/A
  • Revenue Next Year
  • ADAP $52.35
  • NISN N/A
  • P/E Ratio
  • ADAP N/A
  • NISN $16.59
  • Revenue Growth
  • ADAP N/A
  • NISN 8.05
  • 52 Week Low
  • ADAP $0.05
  • NISN $3.22
  • 52 Week High
  • ADAP $1.33
  • NISN $22.55
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 29.42
  • NISN 44.48
  • Support Level
  • ADAP $0.05
  • NISN $3.50
  • Resistance Level
  • ADAP $0.09
  • NISN $3.91
  • Average True Range (ATR)
  • ADAP 0.01
  • NISN 0.16
  • MACD
  • ADAP 0.00
  • NISN -0.03
  • Stochastic Oscillator
  • ADAP 7.21
  • NISN 46.67

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

Share on Social Networks: